THBD and COVID-19: Bouck et al. showed that patients with either coronavirus disease-2019 (COVID-19) or sepsis have elevated fibrinogen, D-dimer, soluble thrombomodulin, and PAP complexes, but detected enhanced PG in patients with COVID-19, and delayed PG in plasma from patients with sepsis [94].